1232 related articles for article (PubMed ID: 22248481)
21. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
[TBL] [Abstract][Full Text] [Related]
22. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
23. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.
Geoffroy V; Kneissel M; Fournier B; Boyde A; Matthias P
Mol Cell Biol; 2002 Sep; 22(17):6222-33. PubMed ID: 12167715
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice.
Valverde P; Zhang J; Fix A; Zhu J; Ma W; Tu Q; Chen J
J Bone Miner Res; 2008 Nov; 23(11):1775-88. PubMed ID: 18597627
[TBL] [Abstract][Full Text] [Related]
25. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
[TBL] [Abstract][Full Text] [Related]
26. Novel bioactivity of phosvitin in connective tissue and bone organogenesis revealed by live calvarial bone organ culture models.
Liu J; Czernick D; Lin SC; Alasmari A; Serge D; Salih E
Dev Biol; 2013 Sep; 381(1):256-75. PubMed ID: 23791550
[TBL] [Abstract][Full Text] [Related]
27. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
28. Measuring mineralised tissue formation and resorption in a human 3D osteoblast-osteoclast co-culture model.
Remmers S; Mayer D; Melke J; Ito K; Hofmann S
Eur Cell Mater; 2020 Nov; 40():189-202. PubMed ID: 33152099
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation.
Robertson KM; Norgård M; Windahl SH; Hultenby K; Ohlsson C; Andersson G; Gustafsson JA
J Bone Miner Res; 2006 Aug; 21(8):1276-87. PubMed ID: 16869726
[TBL] [Abstract][Full Text] [Related]
30. Use of a phage display technique to identify potential osteoblast binding sites within osteoclast lacunae.
Sheu TJ; Schwarz EM; O'Keefe RJ; Rosier RN; Puzas JE
J Bone Miner Res; 2002 May; 17(5):915-22. PubMed ID: 12009023
[TBL] [Abstract][Full Text] [Related]
31. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
32. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
33. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
34. A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells.
Paul S; Lee JC; Yeh LC
Growth Factors; 2009 Apr; 27(2):121-31. PubMed ID: 19180354
[TBL] [Abstract][Full Text] [Related]
35. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
[TBL] [Abstract][Full Text] [Related]
37. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
Rajapurohitam V; Chalhoub N; Benachenhou N; Neff L; Baron R; Vacher J
Bone; 2001 May; 28(5):513-23. PubMed ID: 11344051
[TBL] [Abstract][Full Text] [Related]
38. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
39. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss.
Shandala T; Shen Ng Y; Hopwood B; Yip YC; Foster BK; Xian CJ
J Cell Physiol; 2012 Jul; 227(7):2889-97. PubMed ID: 21938727
[TBL] [Abstract][Full Text] [Related]
40. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]